コンテンツへスキップ
Merck

GE17-5478-06

Capto L

Cytiva 17-5478-06, pack of 5 mL

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
23151817
NACRES:
NA.56

ligand

recombinant protein L (E. coli), mammalian free

包装

pack of 5 mL

メーカー/製品名

Cytiva 17-5478-06

保管条件

(20% Ehtanol)

Matrix

rigid, highly cross-linked agarose

平均部品サイズ

85 μm (d₅₀v is the median particle size of the cumulative volume distribution)

動作範囲

2-10(pH interval where the medium can be operated without significant change in function.)

適合性

suitable for bioprocess medium

保管温度

2-8°C

詳細

Capto L resin is designed for antibody fragment purification, when the fragment contains the kappa light chain.

Capto L combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has a strong affinity to the variable region of antibody kappa light chains.

The high binding capacity and affinity to a broad range of antibody fragments makes this resin an excellent capture platform for antibody fragments containing kappa light chains. Common uses include domain antibody (dAb), scFv, and Fab purification.

Capto L resin requires minimal optimization and produces high purity in one separation step, resulting in significant savings during process development. This resin is also advantageous in manufacturing, because high selectivity of affinity capture reduces the number of subsequent polishing steps.

Scale-up with this resin is straightforward and is further aided by a range of prepacked process development tools, such as PreDictor plates, PreDictor RoboColumn, and HiScreen prepacked columns.

特徴および利点

  • Suitable for the capture of a wide range of antibody fragments such as Fabs, dAbs, and single-chain fragment variable (scFv) .
  • High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of resin.
  • Enables a platform approach to antibody fragment purification.
  • Excellent productivity, process economy, and process design flexibility due to rigid matrix.
  • Hydrophilic base matrix ensures low levels of non-specific binding and low levels of host cell-derived impurities in the elution pool.
  • Fulfills industrial demands for security of supply, robust performance, and regulatory support.

保管および安定性

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

アナリシスノート

この製品の分析証明書は、www.cytiva.com.

法的情報

Capto is a trademark of Cytiva
HiScreen is a trademark of Cytiva

ピクトグラム

Flame

シグナルワード

Warning

危険有害性情報

保管分類コード

3 - Flammable liquids


最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

申し訳ございませんが、現在この製品のCOAをオンラインで入手できません。

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

プロトコル

This page shows how to purify antibody fragments by affinity chromatography using Capto L products from GE Healthcare.

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)